Skip to main content
Premium Trial:

Request an Annual Quote

NIAID to Devote Another $125M to Biocontainment Labs

NEW YORK, May 21 (GenomeWeb News) - The National Institute of Allergy and Infectious Diseases announced on Monday that it plans to provide $125 million in funding in FY 2005 for the construction of five to eight Regional Biocontainment Laboratories.

 

Winning institutions must provide matching funds of at least 25 percent of the total cost of the project. The NIAID will provide at least $15-$25 million in costs.

 

The NationalCenter for Research Resources will also provide an unspecified sum of money for research facilities improvements and upgrades, in collaboration with the NIAID project.

 

The RBLs will support NIAID funded research in biodefense and emerging infectious diseases and will be made available to assist in the case of a national emergency. They will supplement two national biocontainment laboratories and nine other RBLs funded last fall, as well as eight Regional Centers of Excellence in Biodefense and Emerging Infectious diseases. The RCEs will all fund research projects in genomics or proteomics as part of their mandates.

 

The NIAID is not yet soliciting applications for the project. The document announcing the intent to issue a request for applications can be found here.

 

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.